Home/Filings/4/0001062993-24-011979
4//SEC Filing

Kuhlmann Shirley R. 4

Accession 0001062993-24-011979

CIK 0001267565other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 4:06 PM ET

Size

6.9 KB

Accession

0001062993-24-011979

Insider Transaction Report

Form 4
Period: 2024-06-03
Kuhlmann Shirley R.
EVP and General Counsel
Transactions
  • Sale

    Common Stock

    2024-06-03$33.22/sh700$23,254139,409 total
  • Sale

    Common Stock

    2024-06-03$32.55/sh24,300$790,926140,109 total
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2024.
  • [F2]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.18 to $33.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  • [F3]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.19 to $33.31, inclusive.

Issuer

COLLEGIUM PHARMACEUTICAL, INC

CIK 0001267565

Entity typeother

Related Parties

1
  • filerCIK 0001734919

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:06 PM ET
Size
6.9 KB